Latest Mild cognitive impairment Stories
OSAKA, Japan and DURHAM, N.C., July 10, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its partner, Zinfandel Pharmaceuticals, Inc.
Scientists have identified a set of 10 proteins in the blood which can predict the onset of Alzheimer's, marking a significant step towards developing a blood test for the disease.
BOSTON, Mass., May 23, 2014 /PRNewswire/ -- AZTherapies, Inc.
CHICAGO, May 15, 2014 /PRNewswire/ -- The Brain Research Foundation (BRF) today announced that it will provide a major grant that will further research funded by the National Institute of Aging
One of the first studies to look at a relationship between death and the two types of mild cognitive impairment (MCI), or problems with memory and thinking abilities, suggests that people who have thinking problems but their memory is still intact might have a higher death rate in a period of six years compared to those who have no thinking or memory problems.
Mayo Clinic research studying the relationship between death and the two types of mild cognitive impairment (MCI) suggests that people who have these conditions die at a higher rate than people without MCI.
New research from scientists at Stanford University has revealed a genetic variant that raises the risk of developing Alzheimer’s disease in women, but not in men.
WINSTON-SALEM, N.C., March 17, 2014 /PRNewswire-USNewswire/ -- Marcus Dobson first recognized the cognitive decline brought on by Parkinson's disease when he realized he no longer wanted to
A new study reveals that a blood test has been discovered and validated that can predict if a healthy person will develop mild cognitive impairment or Alzheimer's disease within three years.
TSX: AMF TORONTO, Jan. 22, 2014 /CNW/ - Amorfix Life Sciences Ltd.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.